Literature DB >> 8630250

Mechanisms of neuronal degeneration in Alzheimer's disease.

B A Yankner1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630250     DOI: 10.1016/s0896-6273(00)80115-4

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


× No keyword cloud information.
  174 in total

1.  Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice.

Authors:  A L Phinney; T Deller; M Stalder; M E Calhoun; M Frotscher; B Sommer; M Staufenbiel; M Jucker
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons.

Authors:  Q Liu ; H Kawai; D K Berg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 3.  Alzheimer's disease research enters a "new cycle": how significant?

Authors:  A Copani; M A Sortino; F Nicoletti; Stella A M Giuffrida
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

4.  Chronic exposure of NG108-15 cells to amyloid beta peptide (A beta(1-42)) abolishes calcium influx via N-type calcium channels.

Authors:  J Kasparová; V Lisá; S Tucek; V Dolezal
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

5.  Associations between human disease genes and overlapping gene groups and multiple amino acid runs.

Authors:  Samuel Karlin; Chingfer Chen; Andrew J Gentles; Michael Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-09       Impact factor: 11.205

Review 6.  Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.

Authors:  Dennis J Selkoe
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 7.  Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far?

Authors:  Raymond Chuen-Chung Chang; Kwok-Fai So
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

8.  Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.

Authors:  Bao-Xi Qu; Qun Xiang; Liping Li; Stephen Albert Johnston; Linda S Hynan; Roger N Rosenberg
Journal:  J Neurol Sci       Date:  2007-06-15       Impact factor: 3.181

Review 9.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis.

Authors:  J Walter; A Schindzielorz; J Grünberg; C Haass
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.